
    
      A Multi-Center, Randomized, Two-Cohort Phase 2 Study to Evaluate the Safety, Efficacy,
      Pharmacokinetics and Pharmacodynamics of CTAP101 (calcifediol) Extended-Release Capsules to
      Treat Secondary Hyperparathyroidism in Subjects with Vitamin D Insufficiency and Chronic
      Kidney Disease Requiring Regular Hemodialysis.
    
  